INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
659,348
Share change
+17,349
Total reported value
$68,926,488
Price per share
$104.54
Number of holders
104
Value change
+$2,209,043
Number of buys
47
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2025

As of 31 Dec 2025, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 659,348 shares. The largest 10 holders included Peak Asset Management, LLC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Joseph Group Capital Management, MGB Wealth Management, LLC, DUMONT & BLAKE INVESTMENT ADVISORS LLC, and ENVESTNET ASSET MANAGEMENT INC. This page lists 104 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.